<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Activation of the ras oncogene is commonly found in <z:e sem="disease" ids="C0685938" disease_type="Neoplastic Process" abbrv="">gastrointestinal tract cancers</z:e>, but the role of ras in the development and progression of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and associated <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> is uncertain </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: The frequency of K-ras codon 12 point mutations was assessed in 52 paraffin-embedded tissues from 44 patients with oesophageal pathology </plain></SENT>
<SENT sid="2" pm="."><plain>The specimens were classified pathologically as follows: <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the oesophagus or oesophagogastric junction (n = 23), Barrett's high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 5), low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (n = 14), <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> (n = 4), <z:mpath ids='MPATH_458'>normal</z:mpath> oesophagus (n = 5) or <z:mpath ids='MPATH_458'>normal</z:mpath> stomach (n = 1) </plain></SENT>
<SENT sid="3" pm="."><plain>DNA was extracted from three consecutive sections of each paraffin block and mutations at bases 1 and 2 of K-ras codon 12 were identified using a novel restriction endonuclease-mediated selective polymerase chain reaction method </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: Mutations were found in 7 of 23 (30.4%) <z:mp ids='MP_0009308'>adenocarcinomas</z:mp> and in 2 of 5 (40%) high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> specimens </plain></SENT>
<SENT sid="5" pm="."><plain>No mutations were found in specimens of low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> without <z:mpath ids='MPATH_589'>dysplasia</z:mpath>, or <z:mpath ids='MPATH_458'>normal</z:mpath> oesophagus and stomach </plain></SENT>
<SENT sid="6" pm="."><plain>There were no significant associations between the presence of mutations and clinicopathologic features in the patients with <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="7" pm="."><plain>One patient who progressed from low-grade to high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> was found to have developed mutant K-ras in the course of this transformation </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: These results suggest that K-ras codon 12 mutations may occur frequently in patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> with high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> of the oesophagus or oesophagogastric junction </plain></SENT>
<SENT sid="9" pm="."><plain>K-ras mutation may be a late event in the Barrett's <z:mpath ids='MPATH_160'>metaplasia</z:mpath>-<z:mpath ids='MPATH_589'>dysplasia</z:mpath>-<z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence </plain></SENT>
</text></document>